Endolymphatic hydrops induced by chronic administration of vasopressin

By Takeda T.   Takeda S.   Kitano H.   Okada T.   Kakigi A.  

Hearing Research, Vol. 140, Iss. 1, 2000-02 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Signs of endolymphatic hydrops after perilymphatic perfusion of the guinea pig cochlea with cholera toxin; a pharmacological model of acute endolymphatic hydrops

By Lohuis P.J.F.M.   Klis S.F.L.   Klop W.M.C.   van Emst M.G.   Smoorenburg G.F.  

Hearing Research, Vol. 137, Iss. 1, 1999-11 ,pp. : 103-113

Elsevier

Access to resources Recommend Favorite

Use of Oral Vasopressin V₂ Receptor Antagonist for Hyponatremia in Acute Brain Injury

By  

European Neurology, Vol. 70, Iss. 3-4, 2013-07 ,pp. : 142-148

Karger

Access to resources Recommend Favorite

The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

By Dallob Aimee   Luo Wen-Lin   Luk Julie Mabalot   Ratcliffe Lisa   Johnson-Levonas Amy O.   Schwartz Jules I.   Dishy Victor   Kraft Walter K.   De Hoon Jan N.   Van Hecken Anne   De Lepeleire Inge   Radziszewski Waldemar   Wagner John A.   Lai Eseng  

Platelets, Vol. 22, Iss. 7, 2011-11 ,pp. : 495-503

Informa Healthcare

Access to resources Recommend Favorite

Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y 12 antagonist both in-vitro and ex-vivo in human volunteers

By Fox S.C.  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 392-400

Informa Healthcare

Access to resources Recommend Favorite